Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Belgian university discloses novel Amaryllidaceae isocarbostyryl derivatives for cancer

Dec. 7, 2011

Infinity Pharmaceuticals patents novel fatty acid synthase inhibitors

Dec. 7, 2011

U3-1287 combinations assessed in lung and pharynx cancer

Dec. 7, 2011

Human monoclonal antibodies show anticancer potential in preclinical and clinical settings

Dec. 7, 2011

Cell Therapeutics provides update on MAA for Pixuvri

Dec. 5, 2011

Researchers at GlaxoSmithKline disclose new EZH2 inhibitors

Dec. 5, 2011

Sentinel Oncology synthesizes novel Chk1 inhibitors

Dec. 5, 2011

Nerviano Medical Sciences presents preclinical findings on NMS-P948

Dec. 5, 2011

Researchers uncover mechanism of action of epigenetic modifier UVI-5008

Dec. 5, 2011

Celldex Therapeutics begins phase III trial of rindopepimut

Dec. 2, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...